Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction

We report a case of post-awakening recurrent episodes of spontaneous re-sedation and apnea with severe desaturation after procedural sedation with dexmedetomidine and propofol in a leukemic adolescent with an ionic channel variant. The mutation is located in the 3'-UTR regulatory region of SCN9A. We speculate that this variant may affect the stability of the mRNA, making the patient more susceptible to the combined effects of propofol and dexmedetomidine. This is the first pediatric report of late onset re-sedation with apnoea after combined sedation with propofol and dexmedetomidine highlighting the risk of adverse events in selected patients with a genetic increased susceptibility. If validated by further studies, pharmacogenetic testing may be implemented to provide personalized therapies in patients needing anesthesia.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-04-25
DOI
https://doi.org/10.3389/fphar.2025.1549540
Citations
2
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
4.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction

Debora Curci, Valentina Kiren, Gabriele Stocco, Nagua Giurici et al.
2 citations
Frontiers in Pharmacology
Anesthesia and Sedative Agents
4.38
article

Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction

Debora Curci, Valentina Kiren, Gabriele Stocco, Nagua Giurici, Egidio Barbi, Anna Maria Raspolli Galletti, Pio D’Adamo, Marianna Lucafò, Anna Monica Bianco, Sara Solidoro
article en
2 citations

Abstract

We report a case of post-awakening recurrent episodes of spontaneous re-sedation and apnea with severe desaturation after procedural sedation with dexmedetomidine and propofol in a leukemic adolescent with an ionic channel variant. The mutation is located in the 3'-UTR regulatory region of SCN9A. We speculate that this variant may affect the stability of the mRNA, making the patient more susceptible to the combined effects of propofol and dexmedetomidine. This is the first pediatric report of late onset re-sedation with apnoea after combined sedation with propofol and dexmedetomidine highlighting the risk of adverse events in selected patients with a genetic increased susceptibility. If validated by further studies, pharmacogenetic testing may be implemented to provide personalized therapies in patients needing anesthesia.

Frontiers in PharmacologyVol. 16
University of Trieste (IT), IRCCS Materno Infantile Burlo Garofolo (IT)
Openalex Percentile: Top 7%
Anesthesia and Sedative Agents
4.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction — Debora Curci, Valentina Kiren, et al. · Frontiers in Pharmacology (2025) | TGRS Research Map | TGRS